# Bristol-Myers Squibb Company (BMY) — Q4-2024 Earnings Results

**Report date:** 2025-02-06 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2024

## Post-Earnings Brief

### Headline

Bristol-Myers Squibb Beats on EPS, Stock Down 3.84%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.67 | N/A | +14.15% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Bristol-Myers Squibb reported better-than-expected earnings per share, exceeding estimates by 14.15%. However, the stock fell by 3.84% following the announcement, indicating that investors may have been disappointed by the lack of revenue information and guidance. The market reaction suggests uncertainty about the company's future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2024_